For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
If you continue without changing your cookie settings, we'll assume you’re happy with this.
If incorrect, please enter your location into the box below, to view site information related to your location.
Don't have an account?
Custom antibody development and commercial partnerships to advance your diagnostic and therapeutic discovery.
Create custom solutions with us
Partner with us
Visit protocols and troubleshooting or check them out using the Abcam app for iPhone
Protocols and troubleshooting
Full event breakdown with abstracts, speakers, registration and more
View global event calendar
View all pathways
View all interactive pathways
An introduction to dynamin and endocytosis inhibitors. Browse our reference guide.
Test our organelle markers including our RabMAb® range and Alexa Fluor® conjugations. All of our markers have been tested and validated in IF.
Complete guide to selecting microtubule inhibitors, tubulin inhibitors and microtubule-associating protein (MAP) targeting compounds.
This article discusses the connection between D-type cyclins, the cell cycle and cancer. It highlights the targets of the cyclin D-CDK4/6 complexes and provides evidence for cancer development upon deregulation of this complex.